
51 - 200 employees
๐งฌ Biotechnology
๐ Pharmaceuticals
Biotechnology โข Pharmaceuticals
Neurotech Pharmaceuticals, Inc. is a private biotechnology company focused on developing transformative therapies for chronic eye diseases, with a primary therapeutic focus on retinal disorders such as Macular Telangiectasia (MacTel) Type 2. The company develops and commercializes an Encapsulated Cell Therapy (ECT) platform that delivers Ciliary Neurotrophic Factor (CNTF) to protect photoreceptors and slow vision loss; its lead product ENCELTO (revakinagene taroretcel-lwey / NT-501) has received FDA approval for treating MacTel. Neurotech conducts R&D, clinical development, regulatory activities, and commercialization efforts targeting retinal neuroprotection and vision preservation.
๐ June 17
Senior Medical Science Liaison advocating for Neurotech's groundbreaking therapies in chronic eye diseases. Building scientific relationships with key opinion leaders and providing essential medical expertise.
๐ May 26
Senior Director leading access strategy and operations at Neurotech Pharmaceuticals. Collaborating on innovative marketing strategies and managing market access operations for ENCELTO.
๐ May 22
Senior Director of National Accounts at Neurotech Pharmaceuticals handling payer access strategies and brand communications. Collaborating with cross-functional teams to maximize patient access and ensure compliance.